“We Will Deliver Innovative Medicines to Patients”, New Boss of Lilly Korea Appointed
“We Will Deliver Innovative Medicines to Patients”, New Boss of Lilly Korea Appointed
  • Kim Sun, Reporter
  • 승인 2022.08.02 19:00
  • 수정 2022.08.02 19:00
  • 댓글 0
이 기사를 공유합니다

Lilly Korea announced Mr. Christopher J. Stokes (picture) was appointed as new CEO on August 1st.

New CEO is a pharmaceutical and healthcare expert who has built work experiences in global pharmaceutical industry for over 15 years. Before appointment as CEO of Lilly Korea, he has been working as CEO of Eli Lilly South Africa and Sub-Saharan Africa since 2020.

Mr. Stokes first joined the US headquarters of Eli Lilly in 2008 as a public policy analyst, and has since been in charge of public relations, government relations, drug pricing, strategic planning, and new product planning.

After graduating from George Mason University in the US in 2002, he received his master's degree in public administration from Indiana University Bloomington in 2005.

Mr. Stokes said, "As Lilly Korea's new CEO, with a great sense of responsibility, I will do my best to help more Korean patients leading a better life through Lilly's innovative medicines, and furthermore, to deliver a positive impact on Korean society."

[WIKI KOREA=Kim Sun, Reporter]


기자가 쓴 기사

  • 서울특별시 마포구 마포대로 127, 1001호 (공덕동, 풍림빌딩)
  • 대표전화 : 02-702-2677
  • 팩스 : 02-702-1677
  • 청소년보호책임자 : 소정원
  • 법인명 : 위키리크스한국 주식회사
  • 제호 : 위키리크스한국
  • 등록번호 : 서울 아 04701
  • 등록일 : 2013-07-18
  • 발행일 : 2013-07-18
  • 발행인 : 박정규
  • 편집인 : 박찬흥
  • 위키리크스한국은 자체 기사윤리 심의 전문위원제를 운영합니다.
  • 기사윤리 심의 : 박지훈 변호사
  • 위키리크스한국 모든 콘텐츠(영상,기사, 사진)는 저작권법의 보호를 받은바, 무단 전재와 복사, 배포 등을 금합니다.
  • Copyright © 2023 위키리크스한국. All rights reserved.
  • [위키리크스한국 보도원칙] 본 매체는 독자와 취재원 등 뉴스 이용자의 권리 보장을 위해 반론이나 정정보도, 추후보도를 요청할 수 있는 창구를 열어두고 있음을 알립니다.
    고충처리 : 02-702-2677 | 메일 : laputa813@wikileaks-kr.org